LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Dasatinib | 10.0 | uM | LJP6 | 0.1209 | 0.0121 | -0.1909 | 0.0268 |
| MDA-MB-231 | Dovitinib | 10.0 | uM | LJP5 | 0.3921 | 0.0255 | 0.1760 | 0.0425 |
| MDA-MB-231 | Enzastaurin | 10.0 | uM | LJP5 | 1.0363 | 0.0611 | 1.0508 | 0.0834 |
| MDA-MB-231 | Erlotinib | 10.0 | uM | LJP5 | 0.6884 | 0.0422 | 0.5789 | 0.0535 |
| MDA-MB-231 | Foretinib | 10.0 | uM | LJP5 | 0.1654 | 0.0084 | -0.1305 | 0.0215 |
| MDA-MB-231 | R406 | 10.0 | uM | LJP6 | 0.3797 | 0.0567 | 0.1585 | 0.0846 |
| MDA-MB-231 | Pictilisib | 10.0 | uM | LJP6 | 0.4834 | 0.0347 | 0.2996 | 0.0533 |
| MDA-MB-231 | Gefitinib | 10.0 | uM | LJP6 | 0.8967 | 0.0112 | 0.8598 | 0.0163 |
| MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP5 | 0.1500 | 0.0157 | -0.1517 | 0.0323 |
| MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP6 | 0.1308 | 0.0284 | -0.1778 | 0.0489 |
| MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP5 | 0.2402 | 0.0999 | -0.0294 | 0.1377 |
| MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP6 | 0.2629 | 0.0745 | 0.0017 | 0.1015 |
| MDA-MB-231 | GSK1904529A | 10.0 | uM | LJP6 | 0.9357 | 0.0186 | 0.9127 | 0.0254 |
| MDA-MB-231 | Omipalisib | 10.0 | uM | LJP6 | 0.1936 | 0.0520 | -0.0931 | 0.0781 |
| MDA-MB-231 | GSK 690693 | 10.0 | uM | LJP5 | 0.8837 | 0.0309 | 0.8420 | 0.0434 |
| MDA-MB-231 | GW843682X | 10.0 | uM | LJP6 | 0.2779 | 0.0368 | 0.0214 | 0.0566 |
| MDA-MB-231 | HG-5-113-01 | 10.0 | uM | LJP5 | 0.2337 | 0.0339 | -0.0386 | 0.0554 |
| MDA-MB-231 | HG-5-88-01 | 10.0 | uM | LJP6 | 0.5361 | 0.0387 | 0.3725 | 0.0476 |
| MDA-MB-231 | Imatinib | 10.0 | uM | LJP6 | 0.9132 | 0.0118 | 0.8824 | 0.0162 |
| MDA-MB-231 | JNK-9L | 10.0 | uM | LJP6 | 0.1833 | 0.0344 | -0.1070 | 0.0574 |
| MDA-MB-231 | JW-7-24-1 | 10.0 | uM | LJP6 | 0.2084 | 0.0346 | -0.0729 | 0.0569 |
| MDA-MB-231 | Lapatinib | 10.0 | uM | LJP6 | 0.6660 | 0.0496 | 0.5464 | 0.0717 |
| MDA-MB-231 | LDN-193189 | 10.0 | uM | LJP5 | 0.1129 | 0.0095 | -0.2012 | 0.0107 |
| MDA-MB-231 | Linifanib | 10.0 | uM | LJP6 | 0.3800 | 0.0917 | 0.1589 | 0.1301 |
| MDA-MB-231 | Linsitinib | 10.0 | uM | LJP5 | 0.7352 | 0.0559 | 0.6422 | 0.0731 |